In 24 hours, 3,720 positive diagnoses of the disease and 124 deaths were registered. Since the start of the pandemic, 21.5 million people have recovered from covid-19.
Approval was announced today (16), after a technical evaluation by the agency, on the request presented in November, indicating the use of the vaccine for children aged 5 to 11 years.
Anvisa says that, for the inclusion of new audiences in the package insert, it is necessary for the laboratory to carry out studies on the relationship of safety and efficacy for "a certain age group".
According to British authorities, the combination of the Delta and Ômicron variants is at the origin of the sharp increase in infections.